Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: June 8, 2023

Zydus Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for ZYDUS, and what generic and branded alternatives to ZYDUS drugs are available?

ZYDUS has two hundred and seventy-seven approved drugs.

There are twenty-seven tentative approvals on ZYDUS drugs.

Summary for Zydus

US Patents:	0
Tradenames:	235
Ingredients:	234
NDAs:	277
Patent Litigation for Zydus:	See patent lawsuits for Zydus

Drugs and US Patents for Zydus

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zydus Pharms Usa Inc	TOPIRAMATE	topiramate	CAPSULE;ORAL	078877-001	Oct 14, 2009	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Zydus Pharms	EXEMESTANE	exemestane	TABLET;ORAL	202602-001	Oct 3, 2018	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Zydus Pharms	ATORVASTATIN CALCIUM	atorvastatin calcium	TABLET;ORAL	206536-003	Nov 20, 2018	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Zydus Pharms	TOFACITINIB	tofacitinib citrate	TABLET, EXTENDED RELEASE;ORAL	214264-002	Aug 19, 2021		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Zydus Pharms Usa Inc	DIPYRIDAMOLE	dipyridamole	TABLET;ORAL	040874-002	Jan 28, 2008	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Zydus Pharms	BUMETANIDE	bumetanide	TABLET;ORAL	202900-002	Apr 30, 2018	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Zydus Pharms	DOXYCYCLINE	doxycycline	TABLET;ORAL	209582-003	Sep 28, 2017	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for ZYDUS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson

Dow

Mallinckrodt

Moodys

Medtronic

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.